Inflammatory myofibroblastic genitourinary tumor: The challenge of controlling and
monitoring an non frequent oncological disease.Authors:
Luis Rico, Francisco Miguel Lˇpez, Gonzalo Vitagliano
y Ameri Carlos.
Arch. Esp. Urol. 2017; 70 (2): 306-310
Vol. 70, Number. 2, March 2017
OBJECTIVE: The inflammatory myofibroblastic
tumor (IMT) is a neoplasia with intermediate biological
potential, infrequent, with an unpredictable clinical
prognosis and a low recurrence rate after an effective
We report two cases of IMT with genitourinary localization,
being this entity`s publications infrequent. Both presented
with little symptomatology, leading to multiple differential
diagnosis. The surgical treatment was chosen and
pathologic result confirmed the diagnosis.
CONCLUSION: This entity must be considered as a true
malignant neoplasm with aggressive local behavior. The
gold standard management is complete surgical resection,
with low recurrence rate after it. A new oncological
monitoring scheme is proposed, upon the lack of an active
surveillance algorithm after treatment.
ONLY IN SPANISH.